25682-025 : Ultomiris 300 mg/3ml Intravenous Solution, Concentrate

Labeler: Alexion Pharmaceuticals Inc.
Product Type: Human Prescription Drug
Drug Name:  Ultomiris
Dosage Form: Intravenous Solution, Concentrate
Application #: BLA761108
Rev. Date: 

NDC Package Codes:

  • 25682-025-01: 1 VIAL, GLASS IN 1 CARTON (25682‑025‑01) > 3 ML IN 1 VIAL, GLASS

Active Ingredients:

  • Ravulizumab

Dosage Strength:

  • 300 mg/3mL

Pharmaceutical Classes:

  • Complement Inhibitor [EPC]
  • Complement Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 25682-022 Ultomiris 300 mg/30ml Intravenous Solution, Concentrate by Alexion Pharmaceuticals Inc.
  • 25682-028 Ultomiris 1100 mg/11ml Intravenous Solution, Concentrate by Alexion Pharmaceuticals Inc.
  • 25682-031 UltomirisUltomiris Kit by Alexion Pharmaceuticals Inc.


Scan the QR code below to easily reference this data in the future:

NDC 25682-025 QR Code

< Prev: 25682-022Next: 25682-028 >

Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.